What does Alterola Biotech, Inc. do?

Alterola Biotech, Inc. (ABTI) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is ABTI's market cap?

Alterola Biotech, Inc. (ABTI) has a market capitalization of approximately $291,900, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does ABTI pay a dividend?

No — Alterola Biotech, Inc. (ABTI) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Alterola Biotech, Inc. (ABTI) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

ABTI

Alterola Biotech, Inc.

OTC·Drug Manufacturers, Specialty & Generic · Healthcare

$0.00$0.00+0.00%

Market cap$291.90K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−99.99%CAGR −83.21%

Select date range

FromTo

May 5, 2010Aug 27, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

ABTI does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateNov 27

Last Report DateNov 17

Reported vs Estimate−$0.00 vs $1.39

Earnings Surprise−100.0%

FinancialsFinancials Tab

Revenue$0.00

Net Income−$1.20M

Net Margin—

Operating Cash Flow−$874.20K

Capital Expenditures$18.90K

Free Cash Flow−$893.10K

Return on Equity—

Return on Invested Capital26.1%

Net Debt$1.54M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for ABTI and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how ABTI's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ABTI and 80,000+ other tickers.

About Alterola Biotech, Inc.

Alterola Biotech, Inc. is a pharmaceutical company dedicated to the research and development of cannabinoid and cannabinoid-like molecules. The firm primarily focuses on pioneering regulated pharmaceutical products for human and animal health, as well as regulated food items. Key activities also include the production of active pharmaceutical ingredients (APIs) and food-grade components. Furthermore, the company emphasizes drug formulation and advanced delivery systems to improve bioavailability, solubility, and overall stability. It operates out of Birkenhead, United Kingdom.

CEO: David John Hitchcock
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: OTC
Employees: 1
Website: alterola-abti.com

Peers

Peers Tab

BHHKF

Craftport Cannabis Corp.

Cap

$884.0

CPHRF

Cipher Pharmaceuticals Inc.

Cap

$259.0M

ONVVF

Oneview Healthcare PLC

Cap

$122.8M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About ABTI

What does Alterola Biotech, Inc. do?: Alterola Biotech, Inc. (ABTI) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is ABTI's market cap?: Alterola Biotech, Inc. (ABTI) has a market capitalization of approximately $291,900, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does ABTI pay a dividend?: No — Alterola Biotech, Inc. (ABTI) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is ABTI profitable?: Alterola Biotech, Inc. (ABTI) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.